Antiphospholipid Antibody (APLA) level in COVID-19 Cases.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026118
- Lead Sponsor
- DR Rajlaxmi Sarangi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cases: All RT-PCR positive COVID 19 cases admitted to KIMS COVID hospital.
Control: Age and Gender matched apparently healthy Individuals
Exclusion Criteria
•RT-PCR positive COVID 19 cases but donot haveRecent Surgery
•Pregnancy
•Hypertension, CAD, CKD, CLD, Malignancies
•Obesity, smoking
•Associated systemic autoimmune diseases
•Estrogen intake
•Chronic steroid therapy
•Use of anticoagulant medications , vitamin K antagonists.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study will suggest if thrombosis is the major pathology causing seriousness of the disease.Timepoint: This study will suggest if thrombosis is the major pathology causing seriousness of the disease.
- Secondary Outcome Measures
Name Time Method cured/deathTimepoint: Date of admission to 15 days